ERBB2 and metastatic malignant neoplasm in the lymph nodes: Compared to PMBC, MMBC had significantly more lymph node metastasis (p = 0.043), Her2 positivity (p = 0.036), high Ki-67 index (defined as > 20%, p = 0.026) and anti-Her2 targeted therapy (p = 0.016).